{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T20:11:43Z","timestamp":1789157503715,"version":"build-2803163510"},"reference-count":22,"publisher":"ALUNA","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,31]]},"abstract":"<jats:p>Aim: To assess the association between IFNG rs2069709 genotypes (CC, AC), as well as demographic factors such as sex and age, with the risk of complicated varicella in children.\nMaterials and Methods: The study included 132 children with confirmed varicella. Genotyping was performed using PCR with the TaqMan Genotyping Assay. Statistical analysis comprised the \u03c72 test, allele frequency evaluation, and logistic regression to determine the effects of genotype, sex, and age on disease severity.\nResults: The AC genotype was detected in 67.2% of children, while the CC genotype accounted for 20.3%; samples lacking genotype data (12.5%) were excluded from analysis. The C allele predominated in the uncomplicated group (64.2%), whereas the A allele was more frequent among children with complicated varicella (41.3%). Logistic regression demonstrated a tendency toward increased risk of complicated disease in AC carriers (OR=2.05; p=0.10). Sex and age showed no significant association with disease severity (p&gt;0.05). Although statistical significance was not reached, the findings indicate that variability in the IFNG locus may influence individual immune responses to varicella-zoster virus.\nConclusions: The IFNG rs2069709 C allele may act as a protective factor against severe varicella, while the A allele may increase susceptibility to complications. The observed trend for the AC genotype highlights the potential role of genetic markers in predicting disease course. Larger studies are required to confirm these associations and clarify their underlying mechanisms.<\/jats:p>","DOI":"10.36740\/merkur202604106","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:46:13Z","timestamp":1789155973000},"page":"421","source":"Crossref","is-referenced-by-count":0,"title":["Influence of IFNG rs2069709 on the severity of varicella in children"],"prefix":"10.36740","volume":"54","author":[{"given":"Zarina","family":"Alshimbayeva","sequence":"first","affiliation":[{"name":"KARAGANDA MEDICAL UNIVERSITY, KARAGANDA, KAZAKHSTAN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozaliya","family":"Begaydarova","sequence":"additional","affiliation":[{"name":"KARAGANDA MEDICAL UNIVERSITY, KARAGANDA, KAZAKHSTAN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigina","family":"Khodzhayeva","sequence":"additional","affiliation":[{"name":"AVICENNA TAJIK STATE MEDICAL UNIVERSITY, DUSHANBE, TAJIKISTAN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulsharbat","family":"Alshynbekova","sequence":"additional","affiliation":[{"name":"KARAGANDA MEDICAL UNIVERSITY, KARAGANDA, KAZAKHSTAN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulmira","family":"Nasakayeva","sequence":"additional","affiliation":[{"name":"KARAGANDA MEDICAL UNIVERSITY, KARAGANDA, KAZAKHSTAN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulim","family":"Omarova","sequence":"additional","affiliation":[{"name":"KARAGANDA MEDICAL UNIVERSITY, KARAGANDA, KAZAKHSTAN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22436","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"1. Shah HA, Meiwald A, Perera C et al. Global prevalence of varicella-associated complications: a systematic review and meta-analysis. Infect Dis Ther. 2024;13(1):79-103. doi:10.1007\/s40121-023-00899-7.","DOI":"10.1007\/s40121-023-00899-7"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"2. Gershon AA, Breuer J, Cohen JI et al. Varicella zoster virus infection. Nat Rev Dis Primers. 2015;1:15016. doi:10.1038\/nrdp.2015.16.","DOI":"10.1038\/nrdp.2015.16"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"3. Kennedy PGE, Gershon AA. Clinical features of varicella-zoster virus infection. Viruses. 2018;10(11):609. doi:10.3390\/v10110609.","DOI":"10.3390\/v10110609"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"4. Kennedy PGE, Mogensen TH, Cohrs RJ. Recent issues in varicella-zoster virus latency. Viruses. 2021;13(10):2018. doi:10.3390\/v13102018.","DOI":"10.3390\/v13102018"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"5. Ogunjimi B, Zhang SY, Sorensen KB. Inborn errors in RNA polymerase III underlie severe varicella zoster virus infections. J Clin Invest. 2017;127(9):3543-3556. doi:10.1172\/JCI92280.","DOI":"10.1172\/JCI92280"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"6. Jouanguy E, Beziat V, Mogensen TH et al. Human inborn errors of immunity to herpes viruses. Curr Opin Immunol. 2020;62:106-122. doi:10.1016\/j.coi.2020.01.004.","DOI":"10.1016\/j.coi.2020.01.004"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"7. Casanova JL, Abel L. Human genetics of infectious diseases. Semin Immunol. 2018;36:1-12. doi:10.1016\/j.smim.2017.12.008.","DOI":"10.1016\/j.smim.2017.12.008"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"8. Weinberg A, Canniff J, Rouphael N et al. Varicella-zoster virus-specific cellular immune responses to the live attenuated zoster vaccine. J Immunol. 2017;199(2):604-612. doi:10.4049\/jimmunol.1700290.","DOI":"10.4049\/jimmunol.1700290"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"9. Cheng L, Zhang F, Wang Y et al. Association between IFNGR1 gene polymorphisms and tuberculosis susceptibility: a meta-analysis. Front Public Health. 2022;10:976221. doi:10.3389\/fpubh.2022.976221.","DOI":"10.3389\/fpubh.2022.976221"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"10. Kaymaz S, Kavas M, Demiray A et al. Interferon-gamma receptor 1 -56C\/T gene polymorphism and genetic susceptibility to sarcoidosis. Arch Rheumatol. 2022;38(1):1-8. doi:10.46497\/ArchRheumatol.2022.9239.","DOI":"10.46497\/ArchRheumatol.2022.9239"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"11. Girault V, Stukalov A, Carter-Timofte ME et al. Multi-proteomic profiling of the varicella-zoster virus-host interface reveals host susceptibilities to severe infection. Nat Microbiol. 2025;10(8). doi:10.1038\/s41564-025-02068-7.","DOI":"10.1038\/s41564-025-02068-7"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"12. Heininger U, Seward JF. Varicella. Lancet. 2006;368(9544):1365-1376.","DOI":"10.1016\/S0140-6736(06)69561-5"},{"key":"ref12","unstructured":"13. Onishchenko NV, Riabokon YY, Abramov AV. The role of interleukin-10 gene polymorphism in VZV infections. Zaporozhye Med J. 2020;22(1). doi:10.14739\/2310-1210.2020.1.194518."},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"14. Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccine Immunol. 2010;17(7):1055-65. doi: 10.1128\/CVI.00131-10.","DOI":"10.1128\/CVI.00131-10"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"15. Ziebold C , von Kries R, Lang R et al. Severe complications of varicella in previously healthy children in Germany: a 1-year survey. Pediatrics. 2001;108(5):E79.","DOI":"10.1542\/peds.108.5.e79"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"16. Wang H, Chen G, Gang Q. Primary immunodeficiency-related genes and varicella-zoster virus reactivation syndrome: a Mendelian randomization study. Front Immunol. 2024;15:1403429. doi:10.3389\/fimmu.2024.1403429.","DOI":"10.3389\/fimmu.2024.1403429"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"17. Kaymaz S, Kavas M, Demiray A et al. Investigation of the relationship between interferon-gamma receptor 1-56C\/T gene polymorphism and genetic susceptibility to lung sarcoidosis: a cross-sectional study. Arch Rheumatol. 2022;38(1):1-8. doi: 10.46497\/ArchRheumatol.2022.9239.","DOI":"10.46497\/ArchRheumatol.2022.9239"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"18. Yawn BP, Gilden D. The global epidemiology of herpes zoster. Neurology. 2013;81(10):928-30. doi: 10.1212\/WNL.0b013e3182a3516e.","DOI":"10.1212\/WNL.0b013e3182a3516e"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"19. Yu X, Lophatananon A, Mekli K et al. Exploring the causal role of the immune response to VZV on multiple traits. BMC Med. 2023;21(1). doi: 10.1186\/s12916-023-02843-5.","DOI":"10.1186\/s12916-023-02843-5"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"20. Zhang S-Y, Jouanguy E, Ugolini S et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science. 2007;317(5844):1522-1527. doi: 10.1126\/science.1139522.","DOI":"10.1126\/science.1139522"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"21. Sampaio EP, Hsu AP, Pechacek J et al. Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and viral infections. J Allergy Clin Immunol. 2013;131(6):1624-34. doi: 10.1016\/j.jaci.2013.01.052.","DOI":"10.1016\/j.jaci.2013.01.052"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"22. Alshimbayeva ZE, Begaidarova RKh, Kadyrova IA et al. Virus vetryanoy ospy: yestestvennoye techeniye, klinicheskiye proyavleniya, immunitet, geneticheskoye raznoobraziye, tekushchiye i budushchiye strategii vaktsinatsii. [Varicella-zoster virus: natural history, clinical manifestations, immunity, genetic diversity, current and future vaccination strategies. Medicine and Ecology]. Meditsina i ekologiya. 2025;114(1):30-38. (Russian)","DOI":"10.59598\/ME-2305-6053-2025-114-1-30-38"}],"container-title":["Polski Merkuriusz Lekarski"],"original-title":[],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:46:22Z","timestamp":1789155982000},"score":1,"resource":{"primary":{"URL":"https:\/\/polskimerkuriuszlekarski.pl\/wp-content\/uploads\/library\/PolMerkurLek2026i4net.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8,31]]},"published-print":{"date-parts":[[2026,8,31]]}},"URL":"https:\/\/doi.org\/10.36740\/merkur202604106","relation":{},"ISSN":["1426-9686"],"issn-type":[{"value":"1426-9686","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,31]]}}}